Serological and T-helper cell responses to human papillomavirus type 16 L1 in women with cervical dysplasia or cervical carcinoma and in healthy controls

Journal of General Virology

Volumn 78, Issue 4, 1997, Pages 917-923

  Luxton, Jenny C ^a   Rose, Robert C ^b   Coletart, Timothy ^c   Wilson, Philip ^c   Shepherd, Philip S ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^c GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; VIRUS ANTIBODY; VIRUS DNA;

ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FEMALE GENITAL TRACT INFECTION; HELPER CELL; HISTOPATHOLOGY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SEROPREVALENCE; UTERINE CERVIX CARCINOMA; UTERINE CERVIX DYSPLASIA; VIRUS IMMUNITY; VIRUS INFECTION; WART VIRUS;

EID: 0030932481     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-78-4-917     Document Type: Article

References (17)

1. Coleman, N., Birley, H. D., Renton, A. M., Hanna, N. F., Ryait, B. K., Byrne, M., Taylor-Robinson, D. & Stanley, M. A. (1994). Immunological events in regressing genital warts. American Journal of Clinical Pathology 102, 768-774.
2. Dillner, J., Wiklund, F., Lenner, P., Eklund, C., Fredriksson-Shanazarian, V., Schiller, J. T., Hibma, M., Hallmans, G. & Stendahl, U. (1995). Antibodies against linear and conformational epitopes of human papillomavirus type 16 that independently associate with incident cervical cancer. International Journal of Cancer 60, 377-382.
3. Galloway, D. A. (1992). Serological assays for the detection of HPV antibodies. In The Epidemiology of Human Papillomavirus and Cervical Cancer, pp. 147-161. Edited by N. Munoz, F. X. Bosch, K. V. Shah & A. Meheus. Lyon, France: IARC Science Publications.
4. Ho, G. Y., Burk, R. D., Klein, S., Kadish, A. S., Chang, C. J., Palan, P., Basu, J., Tachezy, R., Lewis, R. & Romney, S. (1995). Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. Journal of the National Cancer Institute 87, 1365-1371.
5. Kirnbauer, R., Hubbert, N. L., Wheeler, C. M., Becker, T. B., Lowy, D. R. & Schiller, J. T. (1994). A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16. Journal of the National Cancer Institute 86, 494-499.
6. Koutsky, L. A., Holmes, K. K., Critchlow, C. W., Stevens, C. E., Paavonen, J., Beckmann, A. M., DeRouen, T. A., Galloway, D. A., Vernon, D. & Kiviat, N. B. (1992). A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. New England Journal of Medicine 327, 1272-1278.
7. Lorincz, A. T., Reid, R., Jensen, A. B., Greenberg, M. D., Lancaster, M. W. & Kurman, R. J. (1992). Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstetrics and Gynecology 79, 328-337.
8. Nonnenmacher, B., Hubbert, N. L., Kirnbauer, R., Shah, K. V., Munoz, N., Bosch, F. X., de Sanjose, S., Viscidi, R., Lowy, D. R. & Schiller, J. T. (1995). Serologic response to human papillomavirus type 16 virus-like particles in HPV16 DNA positive invasive cervical cancer and cervical intraepithelial neoplasia grade III patients and controls from Colombia and Spain. Journal of Infectious Diseases 172, 19-24.
9. Resnick, R. M., Cornelissen, M. T., Wright, D. K., Eichinger, G. H., Fox, H. S., ter Schegget, J. & Manos, M. M. (1990). Detection and typing of human papillomavirus in archival cervical cancer specimens by DNA amplification with consensus primers. Journal of the National Cancer Institute 82, 1477-1484.
10. Rose, R. C., Bonnez, W., Reichman, R. C. & Garcea, R. L. (1993). Expression of human papillomavirus type 11 L1 protein in insect cells: in vivo and in vitro assembly of virus-like particles. Journal of Virology 67, 1936-1944.
11. Rose, R. C., Bonnez, W., DaRin, C., McCance, D. J. & Reichman, R. C. (1994a). Serological differentiation of human papillomavirus types 11, 16 and 18 using recombinant virus-like particles. Journal of General Virology 75, 2445-2449.
12. Rose, R. C., Reichman, R. C. & Bonnez, W. (1994b). Human papillomavirus (HPV) type 11 recombinant virus-like particles induce the formation of neutralizing antibodies and detect HPV-specific antibodies in human sera. Journal of General Virology 75, 2075-2079.
13. Shepherd, P. S., Rowe, A. J., Cridland, J. C., Coletart, T., Wilson, P. & Luxton, J. C. (1996). Proliferative T cell responses to human papillomavirus type 16 L1 peptides in patients with cervical dysplasia. Journal of General Virology 77, 593-602.
14. Snijders, P. J., van den Brule, A., Schrijnemakers, H., Snow, G., Meijer, C. & Walboomers, A. (1990). The use of general primers in the polymerase chain reaction permits the detection of a broad spectrum of human papillomavirus genotypes. Journal of General Virology 71, 173-181.
15. van den Brule, A. J., Snijders, P. J., Raaphorst, P. M., Schrijnemakers, H. F., Delius, H., Gissmann, L., Meijer, C. J. & Walboomers, J. M. (1992). General primer polymerase chain reaction in combination with sequence analysis for identification of potentially novel human papillomavirus genotypes in cervical lesions. Journal of Clinical Microbiology 30, 1716.
16. Wikstrom, A., van Doornum, G. J., Quint, W. G., Schiller, J. T. & Dillner, J. (1995). Identification of human papillomavirus seroconversions. Journal of General Virology 76, 529-539.
17. Wright, D. & Manos, M. (1990). Sample preparation from paraffin-embedded tissues. In PCR Protocols: A Guide to Methods and Applications, pp. 153-158. Edited by M. A. Innis, D. H. Gelfand, J. J. Sninsky & T. J. White. San Diego: Academic Press.